Expecting FDA decision on marketing authorization for early-stage low risk breast cancer with endocrine therapy Positive ProSense® results were reported through 33 ...
Investor's Business Daily on MSN57m
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply ChainTariff uncertainty has cast a pall over medical stocks. Re-shoring is possible, but expensive, leaving them in a "wait-and-see" pattern.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback